Oncologists envision a move towards using data to become a learning health system, which is aided by the changing landscape emphasizing quality and value, explained Bobby Green, MD, MSCE, senior vice president of clinical oncology at Flatiron Health.
Oncologists envision a move towards using data to become a learning health system, which is aided by the changing landscape emphasizing quality and value, explained Bobby Green, MD, MSCE, senior vice president of clinical oncology at Flatiron Health.
Transcript (slightly modified)
How can learnings from big data be better incorporated in everyday care?
That question really gets at the point of what is a learning healthcare system. We’re very, very early here, but I think the vision which is shared among a lot of people in this field is that you go from measurement to making interventions to measuring the outcomes that come from those interventions, and then taking those data, understanding what the outcomes of your interventions are, and then feeding that back into the system, so you can learn from what you’ve done before and adjust the interventions that you’re making to further improve care.
I think we’re very, very early, but all of the work that’s being done now ultimately leads to that idea of a learning healthcare system, which was advocated several years ago by the Institute of Medicine. A lot of the work being done now, you can view as being steps towards that ultimate goal.
How has the push toward payment reform advanced the use of data analytics to improve care?
There is no question that the changing landscape is driving a lot of this, and I think the perfect example of that is the Oncology Care Model. Both from a theoretical perspective, now people are starting to think about quality and cost in ways that they weren’t before, but also at a very practical level. CMS is now giving pretty rich claims data to a lot of practices that have never seen data like this before. It’s really opening up a whole new opportunity to take those data, analyze it, understand it, and use it to help practices transform how they’re taking care of patients and to become proficient in the process of care delivery.
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer
April 9th 2025New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with metastatic pancreatic cancer are less likely to receive recommended treatments and achieve longer survival.
Read More
Managing Skin Conditions: Highlighting Ruxolitinib Cream, Phototherapy Efficacy and Cost
April 8th 2025Research presented at the 2025 Academy of Managed Care Pharmacy annual meeting analyzed real-world treatment outcomes for dermatologic conditions, specifically highlighting the efficacy of ruxolitinib cream for atopic dermatitis and the potential for phototherapy to delay costly biologic initiation.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Safety and Efficacy Updates for Asthma and Urticaria Therapies
April 5th 2025The long-term safety and efficacy of omalizumab, alongside promising phase 3 trial results that demonstrated the efficacy and favorable hematological safety profile of remibrutinib, were highlighted at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy Organization Joint Congress.
Read More
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More